NBA In Talks With Disney To Reopen Season At Disney World In July
Gilead’s Remdesivir Most ‘Beneficial’ In Covid-19 Patients Who Need Extra Oxygen, Study Shows
Beleaguered Hertz Sinks 36% In After-Market On Bankruptcy Protection Filing
Weekly Market Review: Re-Opening Drives Rebound
Researchers define exactly what they saw in the first positive remdesivir study for Covid-19. But what's that worth to Gilead?
Three Warren Buffett Tech Stocks to Buy: AMZN, AAPL, STNE
Rebuilding Trust in Coronaworld
The Incoherence Of Yield Curve Control
Foreign direct investment and global value chains in the wake of COVID-19: Preparing for the new normal
Alibaba Scores Earnings Beat With Revenue Surging 22% Y/Y
COVID-19 Worsens Pre-existing Financial Vulnerabilities
Pause in Sino-US trade war, tech war escalates
2 Top Cruise Line Stocks to Buy and 1 to Avoid During the Coronavirus Crisis
Vulcan Materials (VMC) Earnings Report Shows Revenue and EPS Up For Q1 2020
Rainbows, Unicorns, V-Shaped recoveries and other fantasies
Starbucks Regains Almost Two-Thirds Of U.S. Same-Store Sales As Stores Reopen
Foreign direct investment and global value chains in the wake of COVID-19: Lead firms of GVC
Hutchins Roundup: Adjusting the CPI for the pandemic, corporate bond sell-off, and more
Mid-Market Update: Unimpressive US data, China’s Countermeasures, Oil higher and Gold lower on Manufacturing recovery
Some patients with bladder cancer ‘can’t wait’ for treatment during the COVID-19 pandemic
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Gilead, Galapagos claim PhIIb/III win for filgotinib in ulcerative colitis — which pales in comparison to rivals
Deep-Value ETF Report: 21 May 2020
Macro Briefing | 21 May 2020
Gilead Still Holds the Winning Hand, Says 5-Star Analyst
nTIDE May 2020 Special Report: Workers with disabilities in the COVID economy
3 "Strong Buy" Penny Stocks With Substantial Upside Potential
How Off-Price Retailers Could be Big Winners in a Post-COVID World
3 "Strong Buy" Penny Stocks With Over 70% Upside Potential
Worried About Another Market Drop? Buy THIS